Teneligliptin Hydrobromide Hydrate

氢溴酸替格列汀

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameTeneligliptin Hydrobromide Hydrate
Drug Alias Name氢溴酸特力列汀teneligliptina氢溴酸特奈格列汀teneligliptinum替格列汀 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryJapan
Original Approved Date2012/06/29
Country/TerritoryPolandRomaniaHungary +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSuzukenHandok IncDaiichi Sankyo Co Ltd +[5] 
Inactive CompaniesMitsubishi Tanabe Pharma CorpMitsubishi Tanabe Pharma Factory Ltd. Jifu Factory
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10B
Related LinksWikipediaDrugBankKEGG